Acute Otitis Media Treatment Market, by Drug Type (Antibiotics, Nonsteroidal anti-Inflammatory drug, Analgesic, and Anaesthetic), By Formulation (Oral, and Topical), By End User (Hospitals, Retail pharmacies, and Online pharmacies) and Region - Global Trends, and Forecast to 2025

  • Published On : Feb 2018 |
  • Pages : 178 Pages |
  • Format :  

Acute Otitis Media Treatment Market - Insights

Acute otitis media (AOM) is a type of ear infection in which air-filled space behind the eardrum (the middle ear) is infected and causes pain and general symptoms of illness such as fever, irritability and problem in sleeping. AOM is a most common ear infections among children as the Eustachian tube is shorter as compared to adults, which makes it more accessible to bacteria and viruses. Bacteria such as Streptococcus pneumoniae (strep) and Hemophilus influenzae (H. flu) account for around 85% of cases of AOM and viruses account for only 15% of these cases.

Increasing prevalence of AOM disease is expected to drive growth of the acute otitis media treatment market

According to a research published in South African Medical Journal in 2014, global incidence rate of acute otitis media is 10.9% and it was estimated that 80% of children will have at least one episode of acute otitis media (AOM) before the age of 3. Increasing prevalence of acute otitis media is expected to create a conducive environment for growth of acute otitis media treatment market in near future. Furthermore, according to a study published in Formulary Journal in 2014, AOM accounted for healthcare expenditure of around US$ 314 per child per year in the U.S. which is additional US$ 2.88 billion healthcare expenditure. Moreover, stringent guidelines and recommendations in terms of treatment of AOM for children by various non-governmental and governmental bodies is expected to be factor for growth of the market. For instance, in 2013, the American Academy of Pediatrics (AAP) updated the guidelines for treatment of AOM. AAP launched 'The Diagnosis and Management of Acute Otitis Media', in 2013, which provides recommendations to physicians for managing uncomplicated AOM in children. As compared to previous guideline published in 2004, the new guideline has added more criteria for diagnosing AOM. This update in guideline is expected to help in better diagnosis and higher treatment rate, which may boost growth of the global acute otitis media treatment market.

The global acute otitis media treatment market was valued at US$ 1,943.9 million in 2016 and is expected to witness a CAGR of 5.1% over the forecast period (2017–2025).

Figure 1. Global Acute Otitis Media Treatment Market Share (%), By Region, 2017–2025

acute otitis media treatment market

Source: Coherent Market Insights Analysis (2017)

Launch of novel drugs is expected to support growth of acute otitis media treatment market in the near future

Launching of new products for acute otitis media treatment by key players are factors expected to create a conducive environment for market growth in the near future. For instance, in 2016, Laboratorios SALVAT S.A. and Arbor Pharmaceuticals, LLC launched its OTOVEL (ciprofloxacin 0.3 % and fluocinolone acetonide 0.025 %). This solution is indicated for the treatment of acute otitis media with tympanostomy tubes (AOMT) in pediatric patients. Moreover, in 2016, Otonomy, Inc. launched its OTIPRIO (ciprofloxacin otic suspension), indicated for the treatment of pediatric patients with bilateral acute otitis media in the U.S.

Presence of generic drugs, at much lower price compared to branded drugs, in market for the treatment of acute otitis media is the major factor which is expected to hamper the growth in near future. For instance, in 2015, Aurobindo Pharma Ltd. received US FDA approval to launch its generic antibiotic Cefixime in the U.S. market. Cefixime is a third generation cephalosporin indicated for the treatment of acute otitis media.

Furthermore, key players manufacturing drugs for treatment of acute otitis media are focusing on increasing their online presence, by launching websites, in order to expand their customer base. For instance, in 2013, Alcon launched its DROPS101 Web Tools — a mobile website that provides educational resource about commonly prescribed eye and ear treatments. DROPS101 Web Tools offers product information related to the treatment of acute otitis media.

Key players operating in the acute otitis media treatment market include Pfizer, Inc., Eli Lilly and Company, Abbott Laboratories, GlaxoSmithKline plc., Bayer AG, Novartis AG, Pediapharm Inc., Sanofi S.A., and Bristol Myers Squibb Company.

Acute otitis media (AOM) is inflammation of the fluid in the middle ear. AOM is the most common infection and mainly caused in children under the age of 7 years. According to an article published American Family Physician Journal in 2013, around 80% of children will have at least one episode of acute otitis media (AOM) before their school age. AOM is mainly caused by bacteria such as Streptococcus pneumoniae (strep) and Hemophilus influenzae (H. flu) and viruses. Bacteria account for 85% cases of AOM and viruses account for only 15%. AOM is mostly treated with antibiotics usually for 7–10 days and with some analgesic and anesthetic in order to the reduce pain.

Market Dynamics

Increasing prevalence of acute otitis media is expected to be a major driver for growth of the market. Acute otitis media is a very common disease and occurs mostly in children, therefore, increasing prevalence of this disease is expected to increase demand for treatment drugs, thereby positively affecting market growth. According to an article published in The Journal of Laryngology & Otology, in 2013, prevalence of otitis media subtypes is between 7.1–12.8%. Furthermore, recent launches and FDA approvals for new drugs for the treatment of acute otitis media is also expected to drive the market growth in the near future. For instance, in 2015, Otonomy, Inc. received U.S. Food and Drug Administration (FDA) approval for its OTIPRIO (ciprofloxacin otic suspension) indicated for the treatment of pediatric patients with bilateral otitis media with effusion undergoing tympanostomy tube placement. In 2016, Otonomy, Inc. launched OTIPRIO in U.S. market.

Key features of the study:

  • This report provides in-depth analysis of acute otitis media treatment market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017–2025), considering 2016 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
  • It profiles leading players in the global acute otitis media treatment market  based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
  • Key companies covered as a part of this study include Pfizer, Inc., Eli Lilly and Company, Abbott Laboratories, GlaxoSmithKline plc., Bayer AG, Novartis AG, Pediapharm Inc., Sanofi S.A., and Bristol Myers Squibb Company.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global acute otitis media treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the acute otitis media treatment market

Detailed Segmentation:

  • Global Acute Otitis Media Treatment Market, By Drug Type :
    • Antibiotics
    • Nonsteroidal anti-Inflammatory drug
    • Analgesic
    • Anaesthetic
  • Global Acute Otitis Media Treatment Market, By Formulation:
    • Oral
    • Topical
  • Global Acute Otitis Media Treatment Market, By Distribution Channel:
    • Hospital
    • Retail pharmacies
    • Online pharmacies
  • Global Acute Otitis Media Treatment Market, By Geography:
    • North America
      • By Drug Type :
        • Antibiotics
        • Nonsteroidal anti-Inflammatory drug
        • Analgesic
        • Anaesthetic
      • By Formulation
        • Oral
        • Topical
      • By Distribution Channel:
        • Hospital
        • Retail pharmacies
        • Online pharmacies
      • By Country:
        • U.S.
        • Canada
    • Europe
      • By Drug Type :
        • Antibiotics
        • Nonsteroidal anti-Inflammatory drug
        • Analgesic
        • Anaesthetic
      • By Formulation
        • Oral
        • Topical
      • By Distribution Channel:
        • Hospital
        • Retail pharmacies
        • Online pharmacies
      • By Country:
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Drug Type :
        • Antibiotics
        • Nonsteroidal anti-Inflammatory drug
        • Analgesic
        • Anaesthetic
      • By Formulation
        • Oral
        • Topical
      • By Distribution Channel:
        • Hospital
        • Retail pharmacies
        • Online pharmacies
      • By Country:
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • By Drug Type :
        • Antibiotics
        • Nonsteroidal anti-Inflammatory drug
        • Analgesic
        • Anaesthetic
      • By Formulation
        • Oral
        • Topical
      • By Distribution Channel:
        • Hospital
        • Retail pharmacies
        • Online pharmacies
      • By Country:
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East
      • By Drug Type :
        • Antibiotics
        • Nonsteroidal anti-Inflammatory drug
        • Analgesic
        • Anaesthetic
      • By Formulation
        • Oral
        • Topical
      • By Distribution Channel:
        • Hospital
        • Retail pharmacies
        • Online pharmacies
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Drug Type :
        • Antibiotics
        • Nonsteroidal anti-Inflammatory drug
        • Analgesic
        • Anaesthetic
      • By Formulation
        • Oral
        • Topical
      • By Distribution Channel:
        • Hospital
        • Retail pharmacies
        • Online pharmacies
      • By Country:
        • Central Africa
        • South Africa
        • North Africa
  • Company Profiles
    • Pfizer, Inc.*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments
    • Eli Lilly and Company
    • Abbott Laboratories
    • GlaxoSmithKline plc.
    • Bayer AG
    • Novartis AG
    • Pediapharm Inc.
    • Sanofi S.A.
    • Bristol Myers Squibb Company

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Drug Type
      • Market Snippet, By Formulation
      • Market Snippet, By Distribution Channel
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Technological Trends
    • Unmet Needs
    • Regulatory Scenario
    • Recent Product Approvals/Launch
    • Technological Advancement
    • PEST Analysis
    • Porter’s Five Forces Analysis
  4. Global Acute Otitis Media Treatment Market, By Drug Type, 2016–2025 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2016 and 2025 (%)
      • Y-o-Y Growth Analysis, 2016–2025
      • Segment Trends
    • Antibiotics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
    • Nonsteroidal anti-Inflammatory drug
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
    • Analgesic
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
    • Anaesthetic
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
  5. Global Acute Otitis Media Treatment Market, By Formulation, 2017–2025 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2016 and 2025 (%)
      • Y-o-Y Growth Analysis, 2016–2025
      • Segment Trends
    • Oral
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
    • Topical
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
  6. Global Acute Otitis Media Treatment Market, By Distribution Channel, 2016–2025 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2016 and 2025 (%)
      • Y-o-Y Growth Analysis, 2016–2025
      • Segment Trends
    • Hospital
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
    • Retail pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
    • Online pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
  7. Global Acute Otitis Media Treatment Market, By Region, 2016–2025 (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2016 and 2025 (%)
      • Y-o-Y Growth Analysis, For Regions, 2016–2025
    • North America
      • Market Size and Forecast, By Drug Type, 2015–2025 (US$ Mn)
      • Market Size and Forecast, By Formulation, 2015–2025 (US$ Mn)
      • Market Size and Forecast, By Distribution Channel , 2015–2025 (US$ Mn)
      • Market Size and Forecast, By Country, 2015–2025 (US$ Mn)
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast, By Drug Type, 2015–2025 (US$ Mn)
      • Market Size and Forecast, By Formulation, 2015–2025 (US$ Mn)
      • Market Size and Forecast, By Distribution Channel , 2015–2025 (US$ Mn)
      • Market Size and Forecast, By Country, 2015–2025 (US$ Mn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Drug Type, 2015–2025 (US$ Mn)
      • Market Size and Forecast, By Formulation, 2015–2025 (US$ Mn)
      • Market Size and Forecast, By Distribution Channel , 2015–2025 (US$ Mn)
      • Market Size and Forecast, By Country, 2015–2025 (US$ Mn)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of APAC
    • Latin America
      • Market Size and Forecast, By Drug Type, 2015–2025 (US$ Mn)
      • Market Size and Forecast, By Formulation, 2015–2025 (US$ Mn)
      • Market Size and Forecast, By Distribution Channel , 2015–2025 (US$ Mn)
      • Market Size and Forecast, By Country, 2015–2025 (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Africa
      • Market Size and Forecast, By Drug Type, 2015–2025 (US$ Mn)
      • Market Size and Forecast, By Formulation, 2015–2025 (US$ Mn)
      • Market Size and Forecast, By Distribution Channel , 2015–2025 (US$ Mn)
      • Market Size and Forecast, By Country, 2015–2025 (US$ Mn)
        • Central Africa
        • South Africa
        • North Africa
    • Middle East
      • Market Size and Forecast, By Drug Type, 2015–2025 (US$ Mn)
      • Market Size and Forecast, By Formulation, 2015–2025 (US$ Mn)
      • Market Size and Forecast, By Distribution Channel , 2015–2025 (US$ Mn)
      • Market Size and Forecast, By Country, 2015–2025 (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
  8. Competitive Landscape
    • Heat Map Analysis
    • Company Profiles
      • Pfizer, Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Eli Lilly and Company
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Abbott Laboratories
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • GlaxoSmithKline plc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Bayer AG
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Novartis AG
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Pediapharm Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Sanofi S.A.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Bristol Myers Squibb Company
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
  9. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 36 market data tables and 42 figures on “Acute Otitis Media Treatment Market - Global forecast to 2025”.

Research Methodology

Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:

  • Primary Research (Trade Surveys and Experts Interviews)
  • Desk Research
  • Proprietor Data Analytics Model

In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.


Smiley face

Coherent Market Insights desk research is based on a principle set of research techniques:

  • National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.
  • Multinational level desk research: The research team keeps a track of multinational players, global regulatory bodies, global trade associations, and global organization.

Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:

  • Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.
  • Trade association, National and international media and trade press.
  • Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.
  • Scientific journals, and other technical magazines and whitepapers.

Smiley face

Preliminary Data Mining

The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.

Data Standardization:

Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.

Coherent Statistical model

We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:

  • Micro-economic indicators
  • Macro-economic indicators
  • Environmental indicators
  • Socio-political indicators
  • Technology indicators

Data Processing

Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.

Data Validation

This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:

  • It provides first-hand information on the market dynamics, outlook, and growth parameters.
  • Industry experts validates the estimates which helps the company to cement the on-going research study.
  • Primary research includes online surveys, face-to face interviews, and telephonic interviews.

The primary research is conducted with the ecosystem players including, but not limited to:

  • Raw Material Suppliers
  • Manufacturers
  • System Integrators
  • Distributors
  • End-users

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.